[go: up one dir, main page]

EE200300245A - Bensotiofeeni derivaadid, nende valmistamise meetod ja kasutamine - Google Patents

Bensotiofeeni derivaadid, nende valmistamise meetod ja kasutamine

Info

Publication number
EE200300245A
EE200300245A EEP200300245A EEP200300245A EE200300245A EE 200300245 A EE200300245 A EE 200300245A EE P200300245 A EEP200300245 A EE P200300245A EE P200300245 A EEP200300245 A EE P200300245A EE 200300245 A EE200300245 A EE 200300245A
Authority
EE
Estonia
Prior art keywords
preparation
benzothiophene derivatives
benzothiophene
derivatives
Prior art date
Application number
EEP200300245A
Other languages
English (en)
Estonian (et)
Inventor
Carlos Del Castillo Nieto Juan
Esperanza Lasheras Aldaz Berta
Monge Vega Antonio
Mourelle Mancini Marisabel
Del Rio Zambrana Joaquin
Original Assignee
Laboratorios Vita, S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratorios Vita, S.A. filed Critical Laboratorios Vita, S.A.
Publication of EE200300245A publication Critical patent/EE200300245A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/54—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D333/56—Radicals substituted by oxygen atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Thin Film Transistor (AREA)
EEP200300245A 2000-11-29 2001-11-19 Bensotiofeeni derivaadid, nende valmistamise meetod ja kasutamine EE200300245A (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES200002914A ES2188344B1 (es) 2000-11-29 2000-11-29 Compuestos derivados de benzotiofeno, su procedimiento de obtencion y utilizacion de los mismos.
PCT/IB2001/002211 WO2002044170A2 (en) 2000-11-29 2001-11-19 Benzothiophene derivative compounds, process of preparation and use thereof

Publications (1)

Publication Number Publication Date
EE200300245A true EE200300245A (et) 2003-08-15

Family

ID=8495887

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200300245A EE200300245A (et) 2000-11-29 2001-11-19 Bensotiofeeni derivaadid, nende valmistamise meetod ja kasutamine

Country Status (35)

Country Link
US (1) US20040034219A1 (xx)
EP (1) EP1337528B1 (xx)
JP (1) JP2004514719A (xx)
KR (1) KR20030066689A (xx)
CN (1) CN1478088A (xx)
AP (1) AP2003002801A0 (xx)
AR (1) AR034009A1 (xx)
AT (1) ATE272634T1 (xx)
AU (1) AU2002215157A1 (xx)
BG (1) BG107851A (xx)
BR (1) BR0115708A (xx)
CA (1) CA2429892A1 (xx)
CZ (1) CZ20031398A3 (xx)
DE (1) DE60104717T2 (xx)
EA (1) EA200300519A1 (xx)
EE (1) EE200300245A (xx)
ES (2) ES2188344B1 (xx)
GE (1) GEP20043366B (xx)
HR (1) HRP20030407A2 (xx)
HU (1) HUP0303568A3 (xx)
IL (1) IL155966A0 (xx)
IS (1) IS6824A (xx)
MA (1) MA26963A1 (xx)
MX (1) MXPA03004875A (xx)
NO (1) NO20032332D0 (xx)
NZ (1) NZ525950A (xx)
OA (1) OA12536A (xx)
PE (1) PE20020692A1 (xx)
PL (1) PL362982A1 (xx)
PT (1) PT1337528E (xx)
SI (1) SI1337528T1 (xx)
SK (1) SK6202003A3 (xx)
TR (1) TR200402779T4 (xx)
WO (1) WO2002044170A2 (xx)
ZA (1) ZA200303858B (xx)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2323451T7 (es) * 2001-07-20 2011-08-01 Psychogenics Inc. Tratamiento para el trastorno de hiperactividad con deficit de atencion.
MXPA04009318A (es) 2002-03-27 2005-01-25 Glaxo Group Ltd Derivados de quinolina y su uso como ligados 5-ht6.
ES2285407T3 (es) 2003-01-13 2007-11-16 Dynogen Pharmaceuticals Inc. Metodo para el tratamiento de nauseas, vomitos, arcadas o cualquiera de sus combinaciones.
US7276603B2 (en) 2003-05-02 2007-10-02 Wyeth Benzofuranyl-and benzothienyl-piperazinyl quinolines and methods of their use
JP4198733B2 (ja) 2003-07-22 2008-12-17 アリーナ ファーマシューティカルズ， インコーポレイテッド 関連性障害の予防および処置に有用な、５−ｈｔ２ａセロトニンレセプターのモジュレーターとしてのジアリールおよびアリールへテロアリールウレア誘導体
DE102004023632A1 (de) * 2004-05-10 2005-12-08 Grünenthal GmbH Substituierte Cyclohexylcarbonsäure-Derivate
DE102004023501A1 (de) * 2004-05-10 2005-12-01 Grünenthal GmbH Oxosubstituierte Cyclohexyl-1,4-diamin-Derivate
DE102004023635A1 (de) * 2004-05-10 2006-04-13 Grünenthal GmbH Heteroarylsubstituierte Cyclohexyl-1,4-diamin-Derivate
DE102004023522A1 (de) * 2004-05-10 2005-12-01 Grünenthal GmbH Substituierte Cyclohexyl-1,4-diamin-Derivate
DE102004023508A1 (de) * 2004-05-10 2005-12-08 Grünenthal GmbH Säurederivate substituierter Cyclohexyl-1,4-diamine
DE102004023507A1 (de) * 2004-05-10 2005-12-01 Grünenthal GmbH Substituierte Cyclohexylessigsäure-Derivate
DE102004023506A1 (de) * 2004-05-10 2005-12-01 Grünenthal GmbH Kettenverlängerte substituierte Cyclohexyl-1,4-diamin-Derivate
US7881267B2 (en) * 2004-06-04 2011-02-01 Hewlett-Packard Development Company, L.P. Portable computing device for wireless communications and method of operation
DE102004063797A1 (de) * 2004-12-30 2006-07-13 Schwarz Pharma Ag Sauerstoffhaltige annelierte Phenylpiperazin- und Phenyldiazepancarboxamide
US7582634B2 (en) 2005-02-18 2009-09-01 Wyeth 7-substituted imidazo[4,5-c]pyridine antagonists of gonadotropin releasing hormone receptor
US7534796B2 (en) 2005-02-18 2009-05-19 Wyeth Imidazo[4,5-b]pyridine antagonists of gonadotropin releasing hormone receptor
US7538113B2 (en) 2005-02-18 2009-05-26 Wyeth 4-substituted imidazo[4,5-c]pyridine antagonists of gonadotropin releasing hormone receptor
TWI320783B (en) 2005-04-14 2010-02-21 Otsuka Pharma Co Ltd Heterocyclic compound
US7531542B2 (en) 2005-05-18 2009-05-12 Wyeth Benzooxazole and benzothiazole antagonists of gonadotropin releasing hormone receptor
US7582636B2 (en) 2005-05-26 2009-09-01 Wyeth Piperazinylimidazopyridine and piperazinyltriazolopyridine antagonists of Gonadotropin Releasing Hormone receptor
EP2508177A1 (en) 2007-12-12 2012-10-10 Glaxo Group Limited Combinations comprising 3-phenylsulfonyl-8-piperazinyl-1yl-quinoline
US20110021538A1 (en) 2008-04-02 2011-01-27 Arena Pharmaceuticals, Inc. Processes for the preparation of pyrazole derivatives useful as modulators of the 5-ht2a serotonin receptor
CN101619056B (zh) * 2008-07-02 2013-07-17 石药集团中奇制药技术（石家庄）有限公司 苯并噻吩烷醇哌嗪衍生物及其作为抗抑郁症药物的应用
US9126946B2 (en) 2008-10-28 2015-09-08 Arena Pharmaceuticals, Inc. Processes useful for the preparation of 1-[3-(4-bromo-2-methyl-2H-pyrazol-3-yl)-4-methoxy-phenyl]-3-(2,4-difluoro-phenyl)urea and crystalline forms related thereto
CN104337812B (zh) 2013-07-29 2018-09-14 广东东阳光药业有限公司 取代的杂芳基化合物及其使用方法和用途
WO2016192657A1 (en) 2015-06-03 2016-12-08 Sunshine Lake Pharma Co., Ltd. Substituted piperazine compounds and methods of use and use thereof
WO2016201373A1 (en) 2015-06-12 2016-12-15 Axovant Sciences Ltd. Diaryl and arylheteroaryl urea derivatives useful for the prophylaxis and treatment of rem sleep behavior disorder
HK1247555A1 (zh) 2015-07-15 2018-09-28 Axovant Sciences Gmbh 用於预防和治疗与神经变性疾病相关的幻觉的作为5-ht2a血清素受体的调节剂的二芳基脲和芳基杂芳基脲衍生物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4487773A (en) * 1981-03-16 1984-12-11 Mead Johnson & Company 1,2,4-Triazol-3-one antidepressants
ZA929008B (en) * 1991-12-13 1993-05-21 Bristol Myers Squibb Co Piperazinyl- and piperidinyl-cyclohexanols.
FR2692264B1 (fr) * 1992-06-12 1994-08-05 Adir Nouvelles piperazines 1,4-disubstituees, leur procede de preparation et les compositions pharmaceutiques les contenant.
US5658909A (en) * 1994-11-17 1997-08-19 Molecular Geriatrics Corporation Certain substituted 1-aryl-3-piperazin-1'-yl propanones to treat Alzheimer's Disease
US5693804A (en) * 1994-11-17 1997-12-02 Molecular Geriatrics Corporation Substituted 1-aryl-3-piperazin-1'-yl propanones
ES2128266B1 (es) * 1997-07-08 2000-01-16 Vita Invest Sa Compuestos derivados de tiofeno y benzotiofeno y utilizacion y composicion correspondientes.

Also Published As

Publication number Publication date
ATE272634T1 (de) 2004-08-15
GEP20043366B (en) 2004-04-13
HRP20030407A2 (en) 2004-08-31
AP2003002801A0 (en) 2003-06-30
MA26963A1 (fr) 2004-12-20
EP1337528B1 (en) 2004-08-04
MXPA03004875A (es) 2005-02-14
US20040034219A1 (en) 2004-02-19
AR034009A1 (es) 2004-01-21
EP1337528A2 (en) 2003-08-27
TR200402779T4 (tr) 2004-11-22
CA2429892A1 (en) 2002-06-06
BG107851A (bg) 2004-06-30
WO2002044170A2 (en) 2002-06-06
ZA200303858B (en) 2004-05-19
ES2225623T3 (es) 2005-03-16
WO2002044170A3 (en) 2002-09-06
OA12536A (en) 2006-06-05
NO20032332L (no) 2003-05-22
IL155966A0 (en) 2003-12-23
HUP0303568A2 (hu) 2004-03-01
ES2188344A1 (es) 2003-06-16
AU2002215157A1 (en) 2002-06-11
CZ20031398A3 (cs) 2004-01-14
IS6824A (is) 2003-05-22
PE20020692A1 (es) 2002-09-02
PT1337528E (pt) 2004-11-30
DE60104717T2 (de) 2006-04-06
NZ525950A (en) 2004-11-26
NO20032332D0 (no) 2003-05-22
JP2004514719A (ja) 2004-05-20
DE60104717D1 (de) 2004-09-09
PL362982A1 (en) 2004-11-02
CN1478088A (zh) 2004-02-25
SK6202003A3 (en) 2004-05-04
KR20030066689A (ko) 2003-08-09
EA200300519A1 (ru) 2003-12-25
HUP0303568A3 (en) 2005-02-28
ES2188344B1 (es) 2004-09-16
SI1337528T1 (en) 2005-02-28
BR0115708A (pt) 2004-02-03

Similar Documents

Publication Publication Date Title
EE200300245A (et) Bensotiofeeni derivaadid, nende valmistamise meetod ja kasutamine
EE200100431A (et) 16-halogenoepotilooni derivaadid, nende valmistamismeetod ja farmatseutiline kasutamine
EE200100376A (et) Aromaatsed heterotsüklilised ühendid, nende kasutamine ja meetodid nende valmistamiseks
EE200100684A (et) Indalüülasendatud benseenkarboksamiidid, nende valmistamismeetod, kasutamine ja farmatseutilised kompositsioonid
EE200200704A (et) Uued ühendid, meetod nende valmistamiseks ning nende kasutamine
EE200200470A (et) Uued ühendid, meetod nende valmistamiseks ning nende kasutamine
EE04565B1 (et) Adamantaani derivaadid, nende saamine ja kasutamine
EE04721B1 (et) Fenüülksantiini derivaadid, nende valmistamismeetodid ja kasutamine
NO20024175D0 (no) Azetidinderivater, deres fremstilling og farmasöytiske forbindelser inneholdende de samme
DK1180518T3 (da) 5-pyridyl-1,3-azolforbindelser, fremgangsmåde til fremstilling deraf og anvendelse deraf
EE200200095A (et) Sulfonüülkarboksamiidi derivaadid, nende kasutamine, ravim ja nende valmistamismeetod
NO20012567D0 (no) Azepinoindolderivater, fremstilling og anvendelse derav
EE200200175A (et) Asendatud 2-tio-3,5-ditsüano-4-arüül-6-aminopüridiinid ja nende kasutamine
NO20021379D0 (no) Benzodiazepin-derivater, fremstilling og anvendelse derav
DK1163244T3 (da) Thienopyrimidinforbindelser, fremstilling og anvendelse heraf
EE200300048A (et) Bensimidasooli derivaadid, nende valmistamine ja terapeutiline kasutamine
EE04497B1 (et) Püridopüranoasepiini derivaadid, nende valmistamine ja terapeutiline kasutamine
NO20030800L (no) Aminoalkylbenzoyl-benzofuran- eller benzotiofenderivater, fremgangsmåte forderes fremstilling og preparater inneholdende de samme
HUP0302295A3 (en) Thienodibenzoazulene derivatives, process for their preparation and use thereof
NO20022834L (no) Zeolitt SSZ-50, fremgangsmåte for fremstilling og anvendelse av denne
EE200100422A (et) Epotilooni derivaadid, nende valmistamismeetod jafarmatseutiline kasutamine
DK1334106T3 (da) Imidazolderivater, fremstillingsmetoder deraf og anvendelse deraf
EE200000651A (et) Asoolid, nende valmistamismeetod, kasutamine ja farmatseutiline kompositsioon
EE200200697A (et) Uued ühendid, meetod nende valmistamiseks ning nende kasutamine
EE200300060A (et) Polaarsete rühmadega perfluoroalküülrühma sisaldavad kompleksid, nende valmistamismeetod ja kasutamine

Legal Events

Date Code Title Description
HD1A Correction of address